Association of metabolic syndrome and insulin resistance with congestive heart failure: findings from the Third National Health and Nutrition Examination Survey
Chaoyang Li, Earl S Ford, Lisa C McGuire, Ali H Mokdad, Chaoyang Li, Earl S Ford, Lisa C McGuire, Ali H Mokdad
Abstract
Objective: Congestive heart failure (CHF) has been associated with insulin resistance, but few studies have examined its relationship with metabolic syndrome (MetS). Little is known about whether insulin resistance explains the association between MetS and CHF.
Design: Population-based, cross-sectional surveys.
Setting: Third National Health and Nutrition Examination Survey (NHANES III).
Participants: Data from 5549 men and non-pregnant women aged > or =40 years in NHANES III were analysed.
Results: About 4% of men and 3% of women had CHF between 1988 and 1994 in the US. The age-adjusted prevalence of CHF was significantly higher in African Americans (4.1%), in Mexican Americans (8.5%) and in those of other ethnic origin (6.7%) than in white people (2.5%). People with MetS had nearly twice the likelihood of self-reported CHF (adjusted odds ratio 1.8; 95% confidence interval 1.1 to 3.0) after adjustment for demographic and conventional risk factors such as sex, ethnicity, age, smoking, total cholesterol, left ventricular hypertrophy, and probable or possible myocardial infarction determined by electrocardiography. However, this association was attenuated after further adjustment for insulin resistance as measured by the homoeostasis model assessment (HOMA). >90% of the association between MetS and CHF was explained by the HOMA.
Conclusions: MetS was associated with about a twofold increased likelihood of self-reported CHF and it may serve as a surrogate indicator for the association between insulin resistance and CHF.
Conflict of interest statement
Competing interests: None.
Figures
References
- Ford E S, Giles W H, Dietz W H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002287356–359.
- Hanson R L, Imperatore G, Bennett P al Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes 2002513120–3127.
- Laaksonen D E, Lakka H M, Niskanen L al Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 20021561070–1077.
- Ford E S. Risks for all‐cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005281769–1778.
- McNeill A M, Rosamond W D, Girman C al The metabolic syndrome and 11‐year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 200528385–390.
- Pyorala M, Miettinen H, Halonen al Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle‐aged men: the 22‐year follow‐up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 200020538–544.
- Ford E S, Giles W H. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 200326575–581.
- Jessup M, Brozena S. Heart failure. N Engl J Med 20033482007–2018.
- American Heart Association Heart disease and stroke statistics—2005 update. Dallas, TX: AHA, 2005
- Ni H. Prevalence of self‐reported heart failure among US adults: results from the 1999 National Health Interview Survey. Am Heart J 2003146121–128.
- He J, Ogden L G, Bazzano L al Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow‐up study. Arch Intern Med 2001161996–1002.
- Eriksson H, Svardsudd K, Larsson al Risk factors for heart failure in the general population: the study of men born in 1913. Eur Heart J 198910647–656.
- Levy D, Larson M G, Vasan R al The progression from hypertension to congestive heart failure. JAMA 19962751557–1562.
- Kenchaiah S, Evans J C, Levy al Obesity and the risk of heart failure. N Engl J Med 2002347305–313.
- Ingelsson E, Sundstrom J, Arnlov al Insulin resistance and risk of congestive heart failure. JAMA 2005294334–341.
- Swan J W, Anker S D, Walton al Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 199730527–532.
- Stern S E, Williams K, Ferrannini al Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 200554333–339.
- Reaven G M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988371595–1607.
- National Center for Health Statistics Plan and operation of the Third National Health and Nutrition Examination Survey, 1988–94. Series I: programs and collection procedures, Bethesda, MD: National Center for Health Statistics 1994
- Centers for Disease Control and Prevention The Third National Health and Nutrition Examination Survey (NHANES III 1988–94) Reference Manuals and Reports [CD‐Rom]. Bethesda, MD: National Center for Health Statistics, 2005
- Anon Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 20012852486–2497.
- Grundy S M, Brewer H B, Jr, Cleeman J al Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004109433–438.
- International Diabetes Federation The IDF consensus worldwide definition of the metabolic syndrome. (accessed 2 Nov 2006)
- Matthews D R, Hosker J P, Rudenski A al Homeostasis model assessment: insulin resistance and beta‐cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 198528412–419.
- Rautaharju P M, MacInnis P J, Warren J al Methodology of ECG interpretation in the Dalhousie program: NOVACODE ECG classification procedures for clinical trials and population health surveys. Methods Inf Med 199029362–374.
- Research Triangle Institute SUDDAN user's manual, release 8.0. Research Triangle Park, NC: Research Triangle Institute, 2001
- Anderson E A, Hoffman R P, Balon T al Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991872246–2252.
- Holmang A, Yoshida N, Jennische al The effects of hyperinsulinaemia on myocardial mass, blood pressure regulation and central haemodynamics in rats. Eur J Clin Invest 199626973–978.
- Amato L, Paolisso G, Cacciatore al Congestive heart failure predicts the development of non‐insulin‐dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group. Diabetes Metab 199723213–218.
- Paolisso G, Tagliamonte M R, Rizzo M al Prognostic importance of insulin‐mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease. Am J Cardiol 1999831338–1344.
- Paolisso G, De R S, Marrazzo al Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure. Metabolism 199140972–977.
- Stern S E, Williams K, Ferrannini al Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 200554333–339.
- Levantesi G, Macchia A, Marfisi al Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol 200546277–283.
- Chen Y T, Vaccarino V, Williams C al Risk factors for heart failure in the elderly: a prospective community‐based study. Am J Med 1999106605–612.
- Ford E S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005282745–2749.
- Heckbert S R, Kooperberg C, Safford M al Comparison of self‐report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative. Am J Epidemiol 20041601152–1158.
- McKee P A, Castelli W P, McNamara P al The natural history of congestive heart failure: the Framingham Study. N Engl J Med 19712851441–1446.
Source: PubMed